PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29147666-9	2017	In conclusion, 6-OHDA delays reepithelialization during wound healing in diabetic mice by decreasing EGF, but increases wound contraction by reducing IL-1beta levels and the number of MCs.	Oxidopamine	15-21	interleukin 1 beta	Mus musculus	150-158	
11244300-5	2001	First we confirmed that PVN 6-hydroxydopamine lesions, which selectively depleted catecholaminergic terminals, significantly reduced IL-1beta-induced mPVN CRH cell activation.	Oxidopamine	28-45	interleukin 1 beta	Mus musculus	133-141	
10462192-8	1999	Mice in which cerebral norepinephrine was depleted with DSP-4 or 6-hydroxydopamine also displayed the usual hypophagia in response to mIL-1beta and LPS.	Oxidopamine	65-82	interleukin 1 beta	Mus musculus	134-143	
29054324-5	2018	6-OHDA administration elevated levels of tumour necrosis factor-alpha, interferon-gamma, interleukin-1beta, interleukin-2, interleukin-6 and nuclear factor-kappa B and decreased the interleukin-10 levels, total reactive antioxidant potential and total antioxidant reactivity in striatum, as well as, modified the calcium-binding protein B (S100B), brain-derived neurotrophic factor, nerve growth factor and glial cell line-derived neurotrophic factor levels.	Oxidopamine	0-6	interleukin 1 beta	Mus musculus	89-106	
28726961-7	2017	Furthermore, the levels of oxidative stress, tumor necrosis factor (TNF)-alpha and interleukin (IL)-1beta are all reduced significantly in PD mice and the CAR-25 mg kg-1 DA group in comparison with that in 6-OHDA-lesioned mice with saline and 6-OHDA-lesioned mice, as well as the Tyrosine hydroxylase-immunoreactive (TH-ir) density increased (p < 0.01).	Oxidopamine	243-249	interleukin 1 beta	Mus musculus	83-105	
30078232-9	2018	The Rev-erbalpha knockout mice showed prolonged microglial activation in the SN along with the overproduction of interleukin 1beta, a pro-inflammatory cytokine, in response to 6-OHDA.	Oxidopamine	176-182	interleukin 1 beta	Mus musculus	113-130	
28247333-5	2017	Our results indicate that treatment with 6-OHDA promotes microglial polarization toward the M1 state in BV2 microglia cells by increasing the release of interleukin (IL)-6, IL-1beta, or tumor necrosis factor-alpha, which can be prevented by pretreatment with DEX.	Oxidopamine	41-47	interleukin 1 beta	Mus musculus	173-181